-
1
-
-
0036823190
-
Contact hypersensitivity in hand dermatitis
-
Li L. F, Wang J. Contact hypersensitivity in hand dermatitis. Contact dermatitis 2002; 47: 206-209.
-
(2002)
Contact dermatitis
, vol.47
, pp. 206-209
-
-
Li, L.F.1
Wang, J.2
-
2
-
-
34447258147
-
North American Contact Dermatitis Group. Contact dermatitis of the hands: Crosssectional analyses of North American Contact Dermatitis Group Data, 1994-2004
-
Warshaw EM, Ahmed RL, Belsito DV, et al. North American Contact Dermatitis Group. Contact dermatitis of the hands: crosssectional analyses of North American Contact Dermatitis Group Data, 1994-2004. J Am Acad Dermatol 2007; 57: 301-314.
-
(2007)
J Am Acad Dermatol
, vol.57
, pp. 301-314
-
-
Warshaw, E.M.1
Ahmed, R.L.2
Belsito, D.V.3
-
4
-
-
0026575932
-
The mechanism of action of cyclosporine A and FK506
-
Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine A and FK506. Immunol Today 1992; 13: 136-142.
-
(1992)
Immunol Today
, vol.13
, pp. 136-142
-
-
Schreiber, S.L.1
Crabtree, G.R.2
-
5
-
-
1242269913
-
Topical tacrolimus 0.1% ointment (Protopic©) reverses nickel contact dermatitis elucidated by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema
-
Alomar A, Puig L, Crallardo CM, et al. Topical tacrolimus 0.1% ointment (Protopic©) reverses nickel contact dermatitis elucidated by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis 2003; 49: 185-188.
-
(2003)
Contact Dermatitis
, vol.49
, pp. 185-188
-
-
Alomar, A.1
Puig, L.2
Crallardo, C.M.3
-
6
-
-
33744993904
-
A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis
-
Belsito D, Wilson DC, Warshaw E, et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis J Am Acad Dermatol 2006; 55: 40-6.
-
(2006)
J Am Acad Dermatol
, vol.55
, pp. 40-46
-
-
Belsito, D.1
Wilson, D.C.2
Warshaw, E.3
-
7
-
-
0041856226
-
Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis
-
Saripalli Y, Cradgia E, Belsito D. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol 2003; 49: 477-82.
-
(2003)
J Am Acad Dermatol
, vol.49
, pp. 477-482
-
-
Saripalli, Y.1
Cradgia, E.2
Belsito, D.3
-
8
-
-
0036149321
-
Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: A randomized observer-blinded trial
-
Schnopp C, Remling R, Mohsenschlager M, et al. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized observer-blinded trial. J Am Acad Dermatol 2002; 46: 73-7.
-
(2002)
J Am Acad Dermatol
, vol.46
, pp. 73-77
-
-
Schnopp, C.1
Remling, R.2
Mohsenschlager, M.3
-
9
-
-
2342599641
-
Tacrolimus ointment in the treatment of eyelid dermatitis
-
Freeman AK, Serle J, VanVeldhuisen P, et al. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis 2004;73(4):267-71.
-
(2004)
Cutis
, vol.73
, Issue.4
, pp. 267-271
-
-
Freeman, A.K.1
Serle, J.2
van Veldhuisen, P.3
-
10
-
-
0035116403
-
Human epidermal langerhans cells targets for the immunosupressive macrolide tacrolimus
-
Panhans-Gross A, Novak N, Kraft S, et al. Human epidermal langerhans cells targets for the immunosupressive macrolide tacrolimus. J Allergy Clin Immunol 2001; 107:345-52.
-
(2001)
J Allergy Clin Immunol
, vol.107
, pp. 345-352
-
-
Panhans-Gross, A.1
Novak, N.2
Kraft, S.3
-
11
-
-
0037027894
-
Effects of FK506(tacrolimus hydrate)in chronic oxazolone induced dermatitis in rats
-
Fujii Y, Takeuchi H, Tanaka K, et al. Effects of FK506(tacrolimus hydrate)in chronic oxazolone induced dermatitis in rats. Eur J Pharmacol 2002;456(1-3):115-21.
-
(2002)
Eur J Pharmacol
, vol.456
, Issue.1-3
, pp. 115-121
-
-
Fujii, Y.1
Takeuchi, H.2
Tanaka, K.3
-
12
-
-
62149147507
-
Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis
-
Katsarou A, Armenaka M, Vosynioti V, et al. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. J Eur Acad Dermatol Venereol 2009;23(4):382-7.
-
(2009)
J Eur Acad Dermatol Venereol
, vol.23
, Issue.4
, pp. 382-387
-
-
Katsarou, A.1
Armenaka, M.2
Vosynioti, V.3
-
13
-
-
0026786760
-
Inhibition of contact allergy reactions by topical FK506
-
Lauerma AI, Maibach HI, Granlund H, et al. Inhibition of contact allergy reactions by topical FK506. Lancet 1992;340(8818):556.
-
(1992)
Lancet
, vol.340
, Issue.8818
, pp. 556
-
-
Lauerma, A.I.1
Maibach, H.I.2
Granlund, H.3
-
14
-
-
0026588246
-
Immunosupressive macrolides of the type FK506:A novel class of topical agents for treatment of skin diseases
-
Meingassner JG, Stütz A. Immunosupressive macrolides of the type FK506:a novel class of topical agents for treatment of skin diseases. J Invest Dermatol 1992;98(6):851-5.
-
(1992)
J Invest Dermatol
, vol.98
, Issue.6
, pp. 851-855
-
-
Meingassner, J.G.1
Stütz, A.2
-
15
-
-
0028063997
-
Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin
-
Duncan JI. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin. J Invest Dermatol 1994;102(1):84-8.
-
(1994)
J Invest Dermatol
, vol.102
, Issue.1
, pp. 84-88
-
-
Duncan, J.I.1
-
16
-
-
27144508387
-
Eyeglass frame allergic contact dermatitis: Does tacrolimus prevent recurrences?
-
Nakada T, Iijima M, Maibach HI. Eyeglass frame allergic contact dermatitis: does tacrolimus prevent recurrences? Contact dermatitis 2005;53(4):219-21.
-
(2005)
Contact dermatitis
, vol.53
, Issue.4
, pp. 219-221
-
-
Nakada, T.1
Iijima, M.2
Maibach, H.I.3
-
17
-
-
34047217678
-
A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis
-
Bhardwaj SS, Jaimes JP, Liu A, et al. A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis. Dermatitis, 2007;18(1): 26-31.
-
(2007)
Dermatitis
, vol.18
, Issue.1
, pp. 26-31
-
-
Bhardwaj, S.S.1
Jaimes, J.P.2
Liu, A.3
-
18
-
-
37349125327
-
Potential new indications on topical calcineurin inhibitors
-
Epub 2007 Dec 18
-
Luger T, Paul C. Potential new indications on topical calcineurin inhibitors. Dermatology 2007; 215 (Suppl 1):45-54. Epub 2007 Dec 18.
-
(2007)
Dermatology
, vol.215
, Issue.SUPPL. 1
, pp. 45-54
-
-
Luger, T.1
Paul, C.2
|